United Therapeutics | Spese Di Vendita E Di Amministrazione



Selling And Administration Expenses Cambiamento Data
Amarin USD 36.9M 1.64M 2024-09
Ardelyx USD 76.07M 11.1M 2024-12
Baxter International USD 703M 88M 2025-03
Bayer EUR 4.34B 610M 2024-12
Biogen USD 572.5M 104.8M 2025-03
BioMarin Pharmaceutical USD 206.12M 50.65M 2025-03
Gilead Sciences USD 1.26B 603M 2025-03
GlaxoSmithKline GBP 2.06B 603M 2025-03
Halozyme Therapeutics USD 42.25M 1.01M 2024-12
Insmed USD 142.51M 23.58M 2024-12
Ionis Pharmaceuticals USD 76M 12.08M 2025-03
J&J USD 5.11B 1.34B 2025-03
Moderna USD 212M 139M 2025-03
Pfizer USD 3.01B 1.27B 2025-03
PTC Therapeutics USD 84.68M 11.23M 2024-12
Regeneron Pharmaceuticals USD 633M 159.2M 2025-03
Sarepta Therapeutics USD 163.87M 35.67M 2024-12
Teva Pharmaceutical Industries USD 952M 28M 2024-12
United Therapeutics USD 170.1M 7.6M 2025-03
Vertex Pharmaceuticals USD 377.6M 5.8M 2024-12



United Therapeutics Spese Di Vendita E Di Amministrazione - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.